These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 16703528

  • 21. Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine.
    Adler LA, Sutton VK, Moore RJ, Dietrich AP, Reimherr FW, Sangal RB, Saylor KE, Secnik K, Kelsey DK, Allen AJ.
    J Clin Psychopharmacol; 2006 Dec; 26(6):648-52. PubMed ID: 17110824
    [Abstract] [Full Text] [Related]

  • 22. Recognizing ADHD in adults with comorbid mood disorders: implications for identification and management.
    Goodman DW, Thase ME.
    Postgrad Med; 2009 Sep; 121(5):20-30. PubMed ID: 19820271
    [Abstract] [Full Text] [Related]

  • 23. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P, Besana D, Mancini F, Rossi A, Poole L, Escobar R, Zuddas A, LYCY Study Group.
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [Abstract] [Full Text] [Related]

  • 24. Treating adult attention deficit hyperactivity disorder in hospitalized psychiatric patients.
    Castaneda R, Levy R, Hazzi C, Ross S, Roman W, Hamid H.
    Gen Hosp Psychiatry; 2008 Nov; 30(6):572-7. PubMed ID: 19061685
    [Abstract] [Full Text] [Related]

  • 25. ADHD in children, adolescents, and adults.
    Katragadda S, Schubiner H.
    Prim Care; 2007 Jun; 34(2):317-41; abstract viii. PubMed ID: 17666230
    [Abstract] [Full Text] [Related]

  • 26. [Use of methylphenidate in adults with attention deficit disorder with hyperactivity].
    Gauillard J, Castelnau C, Vacheron-Trystram MN, Cheref S, Caroli F.
    Encephale; 1997 Jun; 23(4):251-6. PubMed ID: 9417389
    [Abstract] [Full Text] [Related]

  • 27. Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines.
    Ramos-Quiroga JA, Montoya A, Kutzelnigg A, Deberdt W, Sobanski E.
    Curr Med Res Opin; 2013 Sep; 29(9):1093-104. PubMed ID: 23742051
    [Abstract] [Full Text] [Related]

  • 28. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS, Guilleminault C, Li HY, Yang CM, Wu YY, Chen NH.
    Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
    [Abstract] [Full Text] [Related]

  • 29. [Attention Deficit Hyperactivity Disorder (ADHD) and road traffic - special considerations for the treatment of adolescents with ADHD].
    Ludolph AG, Kölch M, Plener PL, Schulze UM, Spröber N, Fegert JM.
    Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):405-11. PubMed ID: 19739058
    [Abstract] [Full Text] [Related]

  • 30. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
    Niederhofer H.
    Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
    [No Abstract] [Full Text] [Related]

  • 31. [Phonological processing in children with attention deficit hyperactivity disorder: is methylphenidate effective?].
    Miranda-Casas A, Ygual-Fernández A, Mulas-Delgado F, Roselló-Miranda B, Bó RM.
    Rev Neurol; 2002 Feb; 34 Suppl 1():S115-21. PubMed ID: 12447801
    [Abstract] [Full Text] [Related]

  • 32. Current issues and trends in the diagnosis and treatment of adults with ADHD.
    Cumyn L, Kolar D, Keller A, Hechtman L.
    Expert Rev Neurother; 2007 Oct; 7(10):1375-90. PubMed ID: 17939773
    [Abstract] [Full Text] [Related]

  • 33. Attention-deficit hyperactivity disorder.
    Calis KA, Grothe DR, Elia J.
    Clin Pharm; 1990 Aug; 9(8):632-42. PubMed ID: 1974836
    [Abstract] [Full Text] [Related]

  • 34. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P.
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [Abstract] [Full Text] [Related]

  • 35. [Current evidence about atomoxetine. A therapeutic alternative for the treatment of attention deficit hyperactivity disorder].
    Velásquez-Tirado JD, Peña JA.
    Rev Neurol; 2006 Sep; 41(8):493-500. PubMed ID: 16224736
    [Abstract] [Full Text] [Related]

  • 36. OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.
    Ramos-Quiroga JA, Corominas M, Castells X, Bosch R, Casas M.
    Expert Rev Neurother; 2009 Aug; 9(8):1121-31. PubMed ID: 19673602
    [Abstract] [Full Text] [Related]

  • 37. [Update on Current Care guidelines: ADHD (attention-deficit/hyperactivity disorder, children and adolescents)].
    Käypä hoito suosituksen päivitystiivistelmä.
    Duodecim; 2012 Aug; 128(5):539-40. PubMed ID: 22486070
    [Abstract] [Full Text] [Related]

  • 38. Clinical review: evidence-based diagnosis and treatment of ADHD in children.
    Nair J, Ehimare U, Beitman BD, Nair SS, Lavin A.
    Mo Med; 2006 Aug; 103(6):617-21. PubMed ID: 17256270
    [Abstract] [Full Text] [Related]

  • 39. Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
    Wang Y, Zheng Y, Du Y, Song DH, Shin YJ, Cho SC, Kim BN, Ahn DH, Marquez-Caraveo ME, Gao H, Williams DW, Levine LR.
    Aust N Z J Psychiatry; 2007 Mar; 41(3):222-30. PubMed ID: 17464703
    [Abstract] [Full Text] [Related]

  • 40. [Biochemical bases and research in attention-deficit hyperactivity disorder].
    Díaz-Heijtz R.
    Rev Neurol; 2002 Feb; 34 Suppl 1():S78-81. PubMed ID: 12447795
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.